Dr. Bertrand Routy, MD, PhD

Claim this profile

Centre hospitalier de l'Université de Montréal (CHUM)

Studies Lung Cancer

Studies Non-Small Cell Lung Cancer

3 reported clinical trials

4 drugs studied

Area of expertise

1Lung Cancer

Bertrand Routy, MD, PhD has run 3 trials for Lung Cancer. Some of their research focus areas include:

Stage IV

PD-L1 positive

2Non-Small Cell Lung Cancer

Bertrand Routy, MD, PhD has run 3 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:

Stage IV

PD-L1 positive

Affiliated Hospitals

Centre Hospitalier De L'Université De Montréal (CHUM)

Clinical Trials Bertrand Routy, MD, PhD is currently running

More about Bertrand Routy, MD, PhD

Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Bertrand Routy, MD, PhD has experience with

Fecal Microbial Transplantation
Camu Camu Capsules
Immune Checkpoint Inhibitors
Dietary Intervention

Breakdown of trials Bertrand Routy, MD, PhD has run

Lung Cancer

Non-Small Cell Lung Cancer

Melanoma

Skin Cancer

FMT + Immunotherapy for Non-Small Cell Lung Cancer or FMT + Immunotherapy for Melanoma

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

What does Bertrand Routy, MD, PhD specialize in?

Bertrand Routy, MD, PhD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are PD-L1 positive.

Is Bertrand Routy, MD, PhD currently recruiting for clinical trials?

Yes, Bertrand Routy, MD, PhD is currently recruiting for 1 clinical trial in Montréal Quebec. If you're interested in participating, you should apply.

Are there any treatments that Bertrand Routy, MD, PhD has studied deeply?

Yes, Bertrand Routy, MD, PhD has studied treatments such as Fecal Microbial Transplantation, Camu Camu Capsules, Immune Checkpoint Inhibitors.

What is the best way to schedule an appointment with Bertrand Routy, MD, PhD?

Apply for one of the trials that Bertrand Routy, MD, PhD is conducting.

What is the office address of Bertrand Routy, MD, PhD?

The office of Bertrand Routy, MD, PhD is located at: Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec H2X 3E4 Canada. This is the address for their practice at the Centre hospitalier de l'Université de Montréal (CHUM).

Is there any support for travel costs?

The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.

Top trials Bertrand Routy, MD, PhD is currently running

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

1045 Sansome St, Suite 321, San Francisco, CA

hello@withpower.com (415) 900-4227

Directories

Locations

Psychology Related

Treatments

Cities

···

Dr. Bertrand Routy, MD, PhD

Centre hospitalier de l'Université de Montréal (CHUM)

Area of expertise

Affiliated Hospitals

Clinical Trials Bertrand Routy, MD, PhD is currently running

More about Bertrand Routy, MD, PhD

Other Doctors you might be interested in

Frequently asked questions

Personalize Your Experience

Save Your Preferences

Understand How the Site Is Used

Dr. Bertrand Routy, MD, PhD

Centre hospitalier de l'Université de Montréal (CHUM)

Area of expertise

Affiliated Hospitals

Clinical Trials Bertrand Routy, MD, PhD is currently running

High Fiber Diet

for Lung Cancer

This is a single-center randomized trial in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibition. Patients will receive standard-of-care immune checkpoint inhibitor (ICI) therapy alone or in combination with a dietary intervention.

More about Bertrand Routy, MD, PhD

Other Doctors you might be interested in

Frequently asked questions